Pharmaceutical company Aurobindo USA recently broke ground on a new 567,000-square-foot East Windsor facility, which it plans to use at its U.S. corporate headquarters.
The 90-acre East Windsor campus, on Windsor Center Drive across from Route 133 along the Township Route 571 corridor, will include a warehouse, distribution and manufacturing center that is expected to generate new tax dollars and 400 to 500 new jobs when fully operational.
East Windsor Township Mayor Janice S. Mironov, Deputy Mayor Peter Yeager and council members Denise Daniels and John Zoller, as well as Robert Cunard, CEO, Aurobindo USA and P.V. Ramprasad Reddy, Chairperson, Aurobindo, participated in the groundbreaking ceremony.
Aurobindo has now occupied as administrative offices the 43,000-square-foot Patscentre building at Route 571 (Princeton Hightstown Road and Route 535), and by year end will have relocated to this building an additional total of 110 employees. The Patscentre building was designed by renowned British architect Sir Richard Rogers, best known for the Pompidou Cultural Centre in Paris, and was originally occupied by P.A. Technology when it opened in 1984.
”This is an exciting day as the size and scope of this facility marks a significant investment by Aurobindo in East Windsor Township, generating substantial local tax dollars and several hundred new jobs for our area,” said Mayor Mironov. “The selection of East Windsor Township as its new U.S. corporate headquarters and the undertaking of this major new facility underscores once again the tremendous attraction of the township for high-tech, high growth research and development pharmaceutical-related companies. Aurobindo is another great fit within our Einstein’s Alley designation and vision, expanding further the burgeoning pharmaceutical and biotech community here in East Windsor.”
”Aurobindo is very happy to reach this milestone in our growth in New Jersey, and our major expansion to East Windsor,” said Aurobindo USA Chief Executive Officer Robert Cunard. “We have appreciated the valuable assistance and guidance of the mayor and her team in moving forward with our business plans and look forward to becoming part of the East Windsor business community as we make this great site our new U.S. corporate home.” Headquartered in HITEC City, Hyderabad, India, the company was founded in 1986 and becoming a public company in 1992. Aurobindo has business operations in more than 125 countries around the world. It is a global pharmaceutical company with a broad portfolio of generic drugs that includes more than 125 product families and 450 individual product packages. Aurobindo USA is a generic pharmaceutical manufacturer and distributor and is a wholly owned subsidiary of Aurobindo Pharma Limited, a leading generic pharmaceutical company based in India.
The expansion of Aurobindo into East Windsor Township comes at a time of rapid growth for the company. In the past 12 months, Aurobindo has earned the highest number of final Abbreviated New Drug Application FDA approvals among all competitors, and ranks eighth among all generic pharmaceutical companies.
Most recently, Aurobindo announced that the Food and Drug Administration had approved its generic version of Tricor, a drug which treats high cholesterol and high triglycerides. The product had estimated U.S. sales of about $412.1 million for the 12 months ended March 2016, according to IMS Health.
